Zydus Cadila gets USFDA nod for anti-bacterial drug

Drug firm Zydus Cadila said it had received approval from the U.S. Food & Drug Administration to market Azithromycin for Oral Suspension USP, used to treat bacterial infections, in the American market. The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases. The drug will be manufactured at the group’s formulations manufacturing facility at Baddi.

Source : https://www.thehindu.com/todays-paper/tp-business/zydus-cadila-gets-usfda-nod-for-anti-bacterial-drug/article24576849.ece

About ChinmayaIAS Academy - Current Affairs

Check Also

Study indicates association of cloud bursts with forest fires

Are cloud bursts that are increasingly affecting life in the Himalayan foothills linked to the …

Leave a Reply

Your email address will not be published.

Get Free Updates to Crack the Exam!
Subscribe to our Newsletter for free daily updates